To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes

Arch Neurol. 2000 Jul;57(7):930-2. doi: 10.1001/archneur.57.7.930.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Clinical Trials as Topic
  • Demyelinating Diseases / diagnosis
  • Demyelinating Diseases / drug therapy*
  • Disease Progression
  • Glatiramer Acetate
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / therapeutic use
  • Magnetic Resonance Imaging
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / drug therapy*
  • Peptides / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Peptides
  • Interferon beta-1b
  • Glatiramer Acetate
  • Interferon-beta
  • Interferon beta-1a